Literature DB >> 8634455

Intracellular calcium and calcineurin regulate neutrophil motility on vitronectin through a receptor identified by antibodies to integrins alphav and beta3.

B Hendey1, M Lawson, E E Marcantonio, F R Maxfield.   

Abstract

Buffering of intracellular calcium ([Ca2+]i) or inhibition of the calcium/calmodulin-dependent phosphatase, calcineurin, results in neutrophils being unable to detach from vitronectin with a consequent loss of motility. Treatment of [Ca2+]i-buffered or calcineurin-inhibited neutrophils with monoclonal antibodies (MoAbs) to beta3 or alphav beta3 integrins allowed neutrophils to detach and restored motility. Quantitative immunofluorescence and flow cytometry showed that MoAbs specific for beta3, alphav, or alphav beta3 integrins bind to neutrophils. Immunolocalization studies using antibodies to the highly conserved cytoplasmic domains of alphav and beta3 also identified the receptor on neutrophils. Whereas antibodies to alphav, alphav beta3, and beta3 recognized the receptor in intact cells, only the beta3 MoAb immunoprecipitated the receptor from a neutrophil cell lysate. The alpha subunit co-immunoprecipitated by the beta3 antibody reacted with an antibody to alphav by Western blot. Peptide maps of V8 protease digests showed a strong similarity in alpha and beta chains precipitated by antibodies to beta3 from neutrophils and endothelial cells. These results indicate that [Ca2+]i and calcineurin regulate neutrophil motility on vitronectin through an alphav beta3-like receptor. Although we cannot rule out the possibility that neutrophils have an isoform of alphav, such an isoform would have to be similar enough to react with alphav- and alphav beta3-specific MoAbs in intact cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634455

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Calpain inhibition impairs TNF-alpha-mediated neutrophil adhesion, arrest and oxidative burst.

Authors:  Andrew J Wiemer; Mary A Lokuta; Jill C Surfus; Sarah A Wernimont; Anna Huttenlocher
Journal:  Mol Immunol       Date:  2009-11-03       Impact factor: 4.407

2.  Calreticulin couples calcium release and calcium influx in integrin-mediated calcium signaling.

Authors:  M S Kwon; C S Park; K Choi; J Ahnn; J I Kim; S H Eom; S J Kaufman; W K Song
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

3.  Beta 2 (CD18) and beta 1 (CD29) integrin mechanisms in migration of human polymorphonuclear leucocytes and monocytes through lung fibroblast barriers: shared and distinct mechanisms.

Authors:  X Z Shang; A C Issekutz
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

Review 4.  Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action.

Authors:  M E Cardenas; M C Cruz; M Del Poeta; N Chung; J R Perfect; J Heitman
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

5.  Angiostatin inhibits acute lung injury in a mouse model.

Authors:  Gurpreet K Aulakh; Sarabjeet S Suri; Baljit Singh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

6.  Expression of integrin subunits alphav and beta3 in acute lung inflammation.

Authors:  Kyathanahalli S Janardhan; Greg D Appleyard; Baljit Singh
Journal:  Histochem Cell Biol       Date:  2004-04-28       Impact factor: 4.304

7.  Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases.

Authors:  Thaddeus J Wadas; Hongju Deng; Jennifer E Sprague; Alexander Zheleznyak; Katherine N Weilbaecher; Carolyn J Anderson
Journal:  J Nucl Med       Date:  2009-11       Impact factor: 10.057

8.  Delay of migrating leukocytes by the basement membrane deposited by endothelial cells in long-term culture.

Authors:  Victoria J Burton; Lynn M Butler; Helen M McGettrick; Phil C Stone; Hannah C Jeffery; Caroline O Savage; G Ed Rainger; Gerard B Nash
Journal:  Exp Cell Res       Date:  2010-11-04       Impact factor: 3.905

9.  Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors.

Authors:  Liat Goldshaid; Efrat Rubinstein; Alexander Brandis; Dadi Segal; Noa Leshem; Ori Brenner; Vyacheslav Kalchenko; Doron Eren; Tamar Yecheskel; Yoseph Salitra; Yoram Salomon; Avigdor Scherz
Journal:  Breast Cancer Res       Date:  2010-05-24       Impact factor: 6.466

10.  Visualization of integrin molecules by fluorescence imaging and techniques.

Authors:  Chen Cai; Hao Sun; Liang Hu; Zhichao Fan
Journal:  Biocell       Date:  2021-02-19       Impact factor: 1.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.